CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Sam-A Pharmaceutical Company Company Snapshot
Sam-A Pharmaceutical Company operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sam-A Pharmaceutical Company with three other companies in this sector in South Korea: Humedix Co Ltd (2018 sales of 64.83 billion Korean Won [US$54.65 million] ), Choa Pharmaceutical Company Limited (63.09 billion Korean Won [US$53.18 million] of which 75% was Finished Goods(Domestic)), and Pharma Reaserch Products Co Ltd (64.28 billion Korean Won [US$54.19 million] of which 43% was Merchandise-ATP).

Sales Analysis. Sam-A Pharmaceutical Company reported sales of 66.95 billion Korean Won (US$56.44 million) for the year ending December of 2018. This represents an increase of 8.3% versus 2017, when the company's sales were 61.79 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Sam-A Pharmaceutical Company
  Stock Performance Chart for Sam-A Pharmaceutical Company
 
  Stock Data: Recent Stock Performance:
  Current Price (5/17/2019): 17,050
(Figures in Korean Won)
1 Week -3.1%   13 Weeks -8.8%  
4 Weeks -3.7%   52 Weeks -22.0%  
 
Sam-A Pharmaceutical Company Key Data:
  Ticker: 009300 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 66,947,399,195
(Year Ending Jan 2019).
Employees: 308
  Currency: Korean Won Market Cap: 104,061,981,100
  Fiscal Yr Ends: December Shares Outstanding: 6,103,342
  Share Type: Common Closely Held Shares: 4,177,488
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.